Navigation Links
Circadian Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors
Date:10/31/2011

MELBOURNE, Australia, Oct. 31, 2011 /PRNewswire/ -- Circadian Technologies Limited (ASX: CIR, OTCQX: CKDXY) announces that its 100% owned subsidiary, Vegenics Pty Ltd, has received approval for its investigational new drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate clinical trials of VGX-100. The first trial (Phase I) will study VGX-100 in patients with a variety of late stage cancers.

"The FDA's acceptance of our IND represents an extremely important milestone for Circadian. We are well advanced in finalizing clinical trial sites in the USA and expect clinical trials to commence before the end of 2011 with results becoming available from the study in the second half of 2012," said Robert Klupacs, CEO of Circadian Technologies Limited.

VGX-100 is a human antibody that acts against the human VEGF-C protein. Treatment for cancers, particularly glioblastoma and metastatic colorectal cancers, are the first target indications for VGX-100. Additionally, Circadian is developing VGX-100 for a number of other cancer indications, as well as an agent to treat front-of the-eye diseases.

Studies in animal model studies across a wide range of tumour types have shown that when combined with Avastin® and chemotherapy, VGX-100 can significantly reduce tumour growth and tumour spread as well as significantly improve tumour inhibition, over and above that of Avastin® and/or chemotherapy alone. Recent studies have also implicated VEGF-C as a key mediator of disease progression during Avastin® treatment, implying that combination therapy with VGX-100 and Avastin® could significantly improve treatment outcomes in cancer patients.

Circadian's wholly owned subsidiary, Vegenics Pty Ltd, owns worldwide rights to an extensive intellectual property portfolio covering the angiogenesis and lymphangiogenesis targets VEGF-C, VEGF-D and the receptor protein VEGFR-3. Vegenics has also been granted exclu
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy® Systems
4. Mylan Receives Approval for Generic Version of MS Contin® Tablets
5. SAFC Verona HPAPI Manufacturing Facility Receives SafeBridge Certification
6. INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection
7. Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
8. Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial
9. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
10. Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets
11. Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis Corp., ... independent members to its Board of Directors, enhancing ... of the company, a leading licensed producer of ... Internationally, Bedrocan has 13 years, experience in producing ... seven countries, including Canada. As ...
(Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful PSE sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 23,478 boxes of ...
Breaking Medicine Technology:Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/21/2014)... Las Vegas, NV (PRWEB) August 21, 2014 ... - the Association for Packaging and Processing Technologies. ... packaging. It’s the view into a whole new ... thousands of engaged attendees, interactive education, and the ... pharmaceutical lifecycle solutions from exhibitors. This year at ...
(Date:8/21/2014)... 2014 Living in a quality residential ... comes along with it. A quality Home Owners Association ... amenities are available. , Simpson Mill ... and Community Association Management, LLC made a recent investment ... to provide an additional amenity for their neighborhood. , ...
(Date:8/21/2014)... For many people, finding motivation to exercise is a challenge. ... the approach of Zombies, Run!one of more than 31,000 health ... the growing number of apps that use games to increase ... mobile fitness app makers looking to cash in to help ... to exercise remains to be seen. , "It,s just been ...
(Date:8/21/2014)... the environmental source of fungal infections that have been ... literally grows on trees. , The discovery is based ... spent the summer gathering soil and tree samples from ... the fungus named Cryptococcus gattii (CRIP-to-cock-us ... number of species including C. gattii , causes ...
(Date:8/21/2014)... News) -- Being born at a low birth weight puts ... new study suggests. The findings may partly explain high ... high prevalence of low birth weight, the researchers added. ... those with a low birth weight were 13 percent more ... normal birth weight. The risk of diabetes was 40 percent ...
Breaking Medicine News(10 mins):Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Playing hunger games: Are gamified health apps putting odds in your favor? 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2
... 6 million international research consortium to strengthen knowledge of how ... most effectively rebuilt. The REBUILD programme, funded ... will focus on health financing, human resources and their interaction. ... aim to build knowledge about the implications for women, girls ...
... dialysis see their lives inevitably affected by the treatment. ... these kidney patients has improved very little, although it ... starting point, Dr Begoa Ruiz de Alegra studied the ... treatment and domiciliary peritoneal dialysis) in the Basque Country ...
... medicine is one of today,s most exciting scientific and ... ,firsts, new rulings by regulatory bodies or ethical controversies. ... the field, ethicists, legislators, the media and the public. ... than 9,000 of the world,s leading experts in reproductive ...
... People with immune-related disorders such as rheumatoid arthritis and lupus ... clots during hospital stays, a new study has found. ... analyzed 45 years, worth of medical records of patients who ... prior history of blood clots in a vein, also called ...
... research from UC Davis Cancer Center has found that whether ... where they live in addition to their race or ethnicity. ... lower colorectal screening rates than whites, presumably because of differences ... hasn,t been known, until now, is whether these differences also ...
... blood tests require shipping a vial of blood to a laboratory ... device invented by a team of engineers and students at the ... a portable device that provides results in less than 30 minutes. ... testing can be performed in a clinic, in a doctor,s office, ...
Cached Medicine News:Health News:LSTM leads new £6 million ($9.3 million) health systems knowledge consortium 2Health News:Ph.D. thesis shows why patients subjected to dialysis face their illness in different ways 2Health News:Ph.D. thesis shows why patients subjected to dialysis face their illness in different ways 3Health News:ESHRE bridges East and West for its 2012 Congress in Istanbul 2Health News:Immune Disorders May Raise Blood Clot Risk in Hospitalized Patients 2Health News:For non-whites, geography plays key role in colon cancer screening 2Health News:For non-whites, geography plays key role in colon cancer screening 3Health News:Engineering team invents lab-on-a-chip for fast, inexpensive blood tests 2
... Microlite ventilated microcentrifuge combines powerful, quiet performance with ... microcentrifuge that gives you maximum value...MORE for LESS., ... up to 17,000 xg at speeds of 13,500 ... (0.5 mL) microtubes., More Features , ...
... speed of 10,000 rpm , G force ... single- and double-stranded DNA , 3 operation ... 12-position rotor holds 0.5-ml microcentrifuge tubes , ... Replaceable rotor , Safety Features , ...
... accommodate the deep-well Plate Rotor 2 x 96 ... 5600 x g for centrifuging QIAGEN 96-well plates. ... rotors are available from Sigma Laborzentrifugen GmbH for ... tubes, as well as 1.5 ml and 2.0 ...
... up to 25,000 x g for quick and efficient ... of use. The Model 5417 C is designed for ... room and can accommodate a variety of microcentrifuge rotors ... Spin up to 16,400 rpm; 25,000 x g ...
Medicine Products: